Home
>
National Drug Code (NDC)
>
Cytomel
Cytomel - 60793-115-01 - (LIOTHYRONINE SODIUM)
Drug Information of Cytomel
| Product NDC: | 60793-115 |
| Proprietary Name: | Cytomel |
| Non Proprietary Name: | LIOTHYRONINE SODIUM |
| Active Ingredient(s): | 5 ug/1 & nbsp; LIOTHYRONINE SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cytomel
| Product NDC: | 60793-115 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010379 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19560508 |
Package Information of Cytomel
| Package NDC: | 60793-115-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (60793-115-01) |
NDC Information of Cytomel
| NDC Code | 60793-115-01 |
| Proprietary Name | Cytomel |
| Package Description | 100 TABLET in 1 BOTTLE (60793-115-01) |
| Product NDC | 60793-115 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LIOTHYRONINE SODIUM |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19560508 |
| Marketing Category Name | NDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | LIOTHYRONINE SODIUM |
| Strength Number | 5 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
